Clinitech Laboratory IPO Subscription Status
Clinitech Laboratory IPO received bids for 2,22,55,200 shares against 5,71,200 offered, an overall subscription of 38.96x at the close of bidding (29 Jul 2024). Retail leads at 49.61x.
Last updated · day 3 figures
- Retail
- 49.61x
- Total
- 38.96x
Where the demand is
Clinitech Laboratory IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| Others | 3,01,200 | 70,12,800 | ₹67.32 Cr | 23.28x |
| Retail | 3,01,200 | 1,49,41,200 | ₹143.44 Cr | 49.61x |
| Total | 5,71,200 | 2,22,55,200 | ₹213.65 Cr | 38.96x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Clinitech Laboratory IPO subscription day-wise
| Category | Day 3 |
|---|---|
| Others | 23.28x |
| Retail | 49.61x |
| Total | 38.96x |
| Total added | 38.96x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Clinitech Laboratory IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Others | 3,01,200 | 50.00% |
| Retail Individual Investors | 3,01,200 | 50.00% |
| Public issue | 6,02,400 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Clinitech Laboratory IPO subscription: FAQs
- What is the overall subscription of Clinitech Laboratory IPO?
- Clinitech Laboratory IPO is subscribed 38.96x overall as of day 3 (29 July 2024), with bids for 2,22,55,200 shares against 5,71,200 offered.
- What is the retail subscription of Clinitech Laboratory IPO?
- The retail portion is subscribed 49.61x as of day 3 (29 July 2024).
- How can I check Clinitech Laboratory IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Clinitech Laboratory IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 29 July 2024.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.